Nordic Nanovector
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL (NCT03806179) | Nordic Nanovector | 2018-10-04 |
| Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02) (NCT02657447) | Nordic Nanovector | 2017-12-19 |
| Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05) (NCT02658968) | Nordic Nanovector | 2017-03-02 |
| A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (NCT01796171) | Nordic Nanovector | 2012-12-01 |
Track Nordic Nanovector automatically
Every clearance here is in the API, with alerts when new ones post.